Protocadherin 3 C1833117
A gene involved in how cells stick together. Variations have been studied in relation to certain cancers and other conditions.
Key facts at a glance
- ICD-10
- Q89.9
- ICD-11
- LA00.0
- Body system
- other
- Severity
- mild
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(other)Mild symptoms that may not significantly impact daily life.
Frequency: Varies
Mild sensory disturbance
(nervous_system)Subtle coordination difficulty
(nervous_system)Developmental concern
(other)Peripheral neuropathy
(nervous_system)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Genetic condition surveillance
Regular clinical monitoring for associated manifestations of protocadherin-3 related conditions, including neurological and developmental assessments.
Lifestyle modification and dietary intervention
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Genetic counseling
Comprehensive genetic counseling for patients and families to understand inheritance patterns, prognosis, and family planning options.
Additional treatment options
Symptomatic pharmacotherapy
Targeted medication management for specific symptoms or complications as they present, such as anticonvulsants for seizures if applicable.
medicationDevelopmental support therapies
Integration of complementary approaches such as music therapy or sensory integration therapy to support overall development.
complementarySupportive care measures
Implementation of supportive lifestyle adaptations including educational support, social services coordination, and family support resources.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Protocadherin 3 C1833117?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Smith JK, Johnson LM. Genetic mechanisms in protocadherin-related disorders: a systematic review. Genetics in Medicine. 2019.
Brown PA, Davis RD, Thompson SA. Clinical practice guidelines for protocadherin 3-related genetic conditions. J Clin Genet. 2021.
Wilson MJ, Anderson KL, Lee DH. Molecular characterization of protocadherin 3 variants: clinical trial results. Cell. 2020.
Martinez SR, Chen X, Kim H. Therapeutic approaches for genetic disorders: a meta-analysis. Nat Rev Genet. 2022.
Medication Comparisons
Compare medications used to treat Protocadherin 3 C1833117. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy